Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
This study has been terminated.
( Withdrawn due to poor/low accrual )
Study NCT00625183
Information provided by Roswell Park Cancer Institute
First Received on February 26, 2008.
Last Updated on January 31, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
